CAR T-cell therapy in mantle cell lymphoma with secondary CNS involvement: a multicenter experience

Blood Adv. 2024 Jul 9;8(13):3528-3531. doi: 10.1182/bloodadvances.2023012255.
No abstract available

Publication types

  • Multicenter Study

MeSH terms

  • Aged
  • Central Nervous System Neoplasms* / therapy
  • Female
  • Humans
  • Immunotherapy, Adoptive* / methods
  • Lymphoma, Mantle-Cell* / pathology
  • Lymphoma, Mantle-Cell* / therapy
  • Male
  • Middle Aged
  • Receptors, Chimeric Antigen
  • Treatment Outcome

Substances

  • Receptors, Chimeric Antigen